Clinical trial · Observational
Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
iSpecimen Network Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
NCT03884400CI-TRIAL-00062160withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): We have changed our research focus
Summary
Brief summary (as posted)
This protocol seeks to assist biorepositories/biobanks in distributing their stored specimens and data to researchers that will actually utilize them to advance medicine and technology.
Conditions
Conditions (9)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Autoimmune Diseases | — | UNRESOLVED | — |
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Cardio-Respiratory Distress | — | UNRESOLVED | — |
| Gastro-Intestinal Disorder | — | UNRESOLVED | — |
| Healthy | — | UNRESOLVED | — |
| Nephritis | — | UNRESOLVED | — |
| Neuro-Degenerative Disease | — | UNRESOLVED | — |
| Pregnancy Related | — | UNRESOLVED | — |
| Women's Health: Endometriosis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Specimens obtained from surgical, phlebotomy or other non-invasive procedure | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Subjects who have provided consent for specimen collection
- description
- Re-consent will not be required. This protocol allows distribution of the specimens following the terms agreed to by the subject in the original consent.
- interventionNames
- Procedure: Specimens obtained from surgical, phlebotomy or other non-invasive procedure
Primary outcomes (1)
- measure
- Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
- timeFrame
- 15 years
- description
- The number of specimens and subjects distributed per disease will be measured and reported.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Specimens and/or data from Biorepositories that have enrolled subjects that have provided consent for the specimens and de-identified data to be collected, stored and distributed. * Specimens from biobanks that have collected materials and de-identified data under a waiver of consent * Specimens from a biobank that meet the criteria for non human subject research under the common rule. Exclusion Criteria: * Specimens and/or that have been obtained from subjects without informed consent, nor waiver of consent or that do not meet the criteria for non human subject research under the common rule.
References
Publications (0)
Data not yet available
No reference posted for this study.